GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » Inventories, Raw Materials & Components

Waverley Pharma (TSXV:WAVE) Inventories, Raw Materials & Components : C$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Waverley Pharma Inventories, Raw Materials & Components?

Waverley Pharma's inventories, raw materials & components for the quarter that ended in Dec. 2023 was C$0.00 Mil.


Waverley Pharma Inventories, Raw Materials & Components Historical Data

The historical data trend for Waverley Pharma's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma Inventories, Raw Materials & Components Chart

Waverley Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial - - - - -

Waverley Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Waverley Pharma Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Waverley Pharma (TSXV:WAVE) Business Description

Industry
Traded in Other Exchanges
Address
1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6
Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide, among others.

Waverley Pharma (TSXV:WAVE) Headlines

From GuruFocus